Hyperbilirubinemia in the Newborn Bryon J
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Neonatal Orthopaedics
NEONATAL ORTHOPAEDICS NEONATAL ORTHOPAEDICS Second Edition N De Mazumder MBBS MS Ex-Professor and Head Department of Orthopaedics Ramakrishna Mission Seva Pratishthan Vivekananda Institute of Medical Sciences Kolkata, West Bengal, India Visiting Surgeon Department of Orthopaedics Chittaranjan Sishu Sadan Kolkata, West Bengal, India Ex-President West Bengal Orthopaedic Association (A Chapter of Indian Orthopaedic Association) Kolkata, West Bengal, India Consultant Orthopaedic Surgeon Park Children’s Centre Kolkata, West Bengal, India Foreword AK Das ® JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD. New Delhi • London • Philadelphia • Panama (021)66485438 66485457 www.ketabpezeshki.com ® Jaypee Brothers Medical Publishers (P) Ltd. Headquarters Jaypee Brothers Medical Publishers (P) Ltd. 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected] Overseas Offices J.P. Medical Ltd. Jaypee-Highlights Medical Publishers Inc. Jaypee Brothers Medical Publishers Ltd. 83, Victoria Street, London City of Knowledge, Bld. 237, Clayton The Bourse SW1H 0HW (UK) Panama City, Panama 111, South Independence Mall East Phone: +44-2031708910 Phone: +507-301-0496 Suite 835, Philadelphia, PA 19106, USA Fax: +02-03-0086180 Fax: +507-301-0499 Phone: +267-519-9789 Email: [email protected] Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers (P) Ltd. Jaypee Brothers Medical Publishers (P) Ltd. 17/1-B, Babar Road, Block-B, Shaymali Shorakhute, Kathmandu Mohammadpur, Dhaka-1207 Nepal Bangladesh Phone: +00977-9841528578 Mobile: +08801912003485 Email: [email protected] Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2013, Jaypee Brothers Medical Publishers All rights reserved. No part of this book may be reproduced in any form or by any means without the prior permission of the publisher. -
Necrotizing Enterocolitis in a Newborn Following Intravenous Immunoglobulin Treatment for Haemolytic Disease
CASE REPORT Necrotizing Enterocolitis in a Newborn Following Intravenous Immunoglobulin Treatment for Haemolytic Disease Semra Kara1, Hulya Ulu-ozkan2, Yavuz Yilmaz2, Fatma Inci Arikan3, Ugur Dilmen4 and Yildiz Dallar Bilge3 ABSTRACT ABO iso-immunization is the most frequent haemolytic disease of the newborn. Treatment depends on the total serum bilirubin level, which may increase very rapidly in the first 48 hours of life in cases of haemolytic disease of the newborn. Phototherapy and, in severe cases, exchange transfusion are used to prevent hyperbilirubinaemic encephalopathy. Intravenous immunoglobulins (IVIG) are used to reduce exchange transfusion. Herein, we present a female newborn who was admitted to the NICU because of ABO immune haemolytic disease. After two courses of 1 g/kg of IVIG infusion, she developed necrotizing enterocolitis (NEC). Administration of IVIG to newborns with significant hyperbilirubinaemia due to ABO haemolytic disease should be cautiously administered and followed for complications. Key Words: Necrotizing enterocolitis. Hyperbilirubinaemia. Newborn. Intravenous immunoglobulins. Iso-immunization. INTRODUCTION important adverse reactions,6 one of which is described Blood group incompatibilities are most frequent and hereby. severe conditions causing hyperbilirubinaemia in the neonatal period.1 Phototherapy and in severe cases CASE REPORT exchange transfusion are used to prevent kernicterus A female newborn was admitted to our neonatal unit and reduce perinatal mortality. Exchange transfusion because of jaundice on the tenth hours after being born. is not free of severe complications such as thrombo- The baby was born by uncomplicated vaginal delivery to cytopenia, apnoea, pulmonary haemorrhage, haemodyna- a healthy 31-year-old mother who was fourth gravida mic instability, septicaemia and necrotizing enterocolitis and second para. -
Subcutaneous Emphysema, Pneumomediastinum, Pneumoretroperitoneum, and Pneumoscrotum: Unusual Complications of Acute Perforated Diverticulitis
Hindawi Publishing Corporation Case Reports in Radiology Volume 2014, Article ID 431563, 5 pages http://dx.doi.org/10.1155/2014/431563 Case Report Subcutaneous Emphysema, Pneumomediastinum, Pneumoretroperitoneum, and Pneumoscrotum: Unusual Complications of Acute Perforated Diverticulitis S. Fosi, V. Giuricin, V. Girardi, E. Di Caprera, E. Costanzo, R. Di Trapano, and G. Simonetti Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University Hospital Tor Vergata, Viale Oxford 81, 00133 Rome, Italy Correspondence should be addressed to E. Di Caprera; [email protected] Received 11 April 2014; Accepted 7 July 2014; Published 17 July 2014 Academic Editor: Salah D. Qanadli Copyright © 2014 S. Fosi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Pneumomediastinum, and subcutaneous emphysema usually result from spontaneous alveolar wall rupture and, far less commonly, from disruption of the upper airways or gastrointestinal tract. Subcutaneous neck emphysema, pneumomediastinum, and retropneumoperitoneum caused by nontraumatic perforations of the colon have been infrequently reported. The main symptoms of spontaneous subcutaneous emphysema are swelling and crepitus over the involved site; further clinical findings in case of subcutaneous cervical and mediastinal emphysema can be neck and chest pain and dyspnea. Radiological imaging plays an important role to achieve the correct diagnosis and extension of the disease. We present a quite rare case of spontaneous subcutaneous cervical emphysema, pneumomediastinum, and pneumoretroperitoneum due to perforation of an occult sigmoid diverticulum. Abdomen ultrasound, chest X-rays, and computer tomography (CT) were performed to evaluate the free gas extension and to identify potential sources of extravasating gas. -
Consensus Guidelines for Partial Exchange Transfusion for Polycythemia in Neonates UCSF (NC)2 (Northern California Neonatal Consortium)
Consensus Guidelines for Partial Exchange Transfusion for Polycythemia in Neonates UCSF (NC)2 (Northern California Neonatal Consortium) Executive summary Objectives • Standardize the approach to screening and management of polycythemia in infants ≥ 34 weeks gestation using current practice standards and best available evidence • Improve quality and safety of care for neonates ≥ 34 weeks GA with possible polycythemia; specifically: o Improve recognition of infants showing symptoms of polycythemia o Decrease unnecessary screening o Provide recommendations on how to perform partial exchange transfusion safely and effectively o Decrease morbidity associated with unnecessary partial exchange transfusions Recommendations • Who to Screen o Asymptomatic patients should not be routinely screened regardless of risk factors o Only screen symptomatic patients for polycythemia • Who Should Receive Partial Exchange Transfusion o Do NOT perform PET in asymptomatic infant with Hct <=75% o Consider PET in infants with Hct >65% who are demonstrating signs listed in Section A or B on page 3 o Consider PET in asymptomatic infants with Hct >75%, but note there is minimal data for benefit of PET in asymptomatic infants. • Timing of Partial Exchange Transfusion o PET should be performed as soon as possible in symptomatic infants Methods This guideline was developed through local consensus based on published evidence and expert opinion as part of the UCSF Northern California Neonatal Consortium. Metrics Plan UCSF NC2 (Northern California Neonatology Consortium). -
CDHO Advisory Polycythemia, 2018-11-09
CDHO Advisory | P olycythemia COLLEGE OF DENTAL HYGIENISTS OF ONTARIO ADVISORY ADVISORY TITLE Use of the dental hygiene interventions of scaling of teeth and root planing including curetting surrounding tissue, orthodontic and restorative practices, and other invasive interventions for persons1 with polycythemia. ADVISORY STATUS Cite as College of Dental Hygienists of Ontario, CDHO Advisory Polycythemia, 2018-11-09 INTERVENTIONS AND PRACTICES CONSIDERED Scaling of teeth and root planing including curetting surrounding tissue, orthodontic and restorative practices, and other invasive interventions (“the Procedures”). SCOPE DISEASE/CONDITION(S)/PROCEDURE(S) Polycythemia INTENDED USERS Advanced practice nurses Nurses Dental assistants Patients/clients Dental hygienists Pharmacists Dentists Physicians Denturists Public health departments Dieticians Regulatory bodies Health professional students ADVISORY OBJECTIVE(S) To guide dental hygienists at the point of care relative to the use of the Procedures for persons who have polycythemia, chiefly as follows. 1. Understanding the medical condition. 2. Sourcing medications information. 3. Taking the medical and medications history. 4. Identifying and contacting the most appropriate healthcare provider(s) for medical advice. 1 Persons includes young persons and children Page | 1 CDHO Advisory | P olycythemia 5. Understanding and taking appropriate precautions prior to and during the Procedures proposed. 6. Deciding when and when not to proceed with the Procedures proposed. 7. Dealing with adverse events arising during the Procedures. 8. Keeping records. 9. Advising the patient/client. TARGET POPULATION Child (2 to 12 years) Adolescent (13 to 18 years) Adult (19 to 44 years) Middle Age (45 to 64 years) Aged (65 to 79 years) Aged 80 and over Male Female Parents, guardians, and family caregivers of children, young persons and adults with polycythemia. -
Delayed Cord Clamping in Red Blood Cell Alloimmunization: Safe, Effective, and Free?
Editorial Delayed cord clamping in red blood cell alloimmunization: safe, effective, and free? Ryan M. McAdams Department of Pediatrics, University of Washington, Seattle, WA, USA Correspondence to: Ryan M. McAdams, MD, Associate Professor. Division of Neonatology, Department of Pediatrics, University of Washington, Box 356320, Seattle, WA 98195-6320, USA. Email: [email protected]. Abstract: Hemolytic disease of the newborn (HDN), an alloimmune disorder due to maternal and fetal blood type incompatibility, is associated with fetal and neonatal complications related to red blood cell (RBC) hemolysis. After delivery, without placental clearance, neonatal hyperbilirubinemia may develop from ongoing maternal antibody-mediated RBC hemolysis. In cases refractory to intensive phototherapy treatment, exchange transfusions (ET) may be performed to prevent central nervous system damage by reducing circulating bilirubin levels and to replace antibody-coated red blood cells with antigen-negative RBCs. The risks and costs of treating HDN are significant, but appear to be decreased by delayed umbilical cord clamping at birth, a strategy that promotes placental transfusion to the newborn. Compared to immediate cord clamping (ICC), safe and beneficial short-term outcomes have been demonstrated in preterm and term neonates receiving delayed cord clamping (DCC), a practice that may potentially be effective in cases RBC alloimmunization. Keywords: Red blood cell (RBC); delayed cord clamping (DCC); exchange transfusions (ET) Submitted Mar 29, 2016. Accepted for publication Apr 11, 2016. doi: 10.21037/tp.2016.04.02 View this article at: http://dx.doi.org/10.21037/tp.2016.04.02 Hemolytic disease of the newborn (HDN) is an alloimmune exchange transfusions (ET) may be performed to prevent disorder caused by transplacentally transmitted maternal kernicterus by reducing circulating bilirubin levels and immunoglobulin (Ig) G antibodies that bind to paternally to replace antibody-coated RBCs with antigen-negative inherited antigens present on fetal red blood cells RBCs. -
JMSCR Vol||05||Issue||03||Page 19659-19665||March 2017
JMSCR Vol||05||Issue||03||Page 19659-19665||March 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i3.210 Maternal and Neonatal Determinants of Neonatal Jaundice – A Case Control Study Authors Sudha Menon1, Nadia Amanullah2 1Additional Professor, Department of Obstetrics and Gynecology, Government Medical College Trivandrum, Kerala, South India 2Msc Nursing Student, Government Nursing College, Trivandrum Corresponding Author Dr Sudha Menon Email: [email protected] ABSTRACT Neonatal jaundice a common condition which affects about 60-80% of newborn and if severe can lead serious neurological sequelae. Determinants include neonatal and maternal factors. A prospective case control descriptive study in a tertiary care centre was done in 62 consecutive cases with neonatal jaundice and 124 consecutive newborns without jaundice served as controls. The major determinants for neonatal jaundice were low birth weight <2.5 kg (OR 24.54 95% CI 10.98 – 54.84 : P<0.0001), birth asphyxia (OR 16.5; 95% CI 4.63- 58.76, P<0.0001), Low APGAR score <7( OR 26.1; 95% CI 3.28- 207.47, P =0.0002), prematurity <37weeks ( OR 28.92 95% CI 12.15-68.82 P=0.0001) Preterm premature rupture of membranes (OR 58.57 95% CI 7.67 -449.87 P<0.0001) and malpresentation (OR 14.64 95% CI 3.16 - 67.792 tailed p =0.00004).The factors which evolved significant on logistic regression were Preterm premature rupture of membranes , gestational age <37 weeks , APGAR score below 7, Birth weight below 2500grams, Birth asphyxia and multiple pregnancy. -
Newborn Metabolic Profile Associated with Hyperbilirubinemia with and Without Kernicterus
Citation: Clin Transl Sci (2019) 12, 28–38; doi:10.1111/cts.12590 ARTICLE Newborn Metabolic Profile Associated with Hyperbilirubinemia With and Without Kernicterus Molly E. McCarthy1,2,*, Scott P. Oltman3, Rebecca J. Baer4,5, Kelli K. Ryckman6, Elizabeth E. Rogers7, Martina A. Steurer-Muller8, John S. Witte9 and Laura L. Jelliffe-Pawlowski10 Our objective was to assess the relationship between hyperbilirubinemia with and without kernicterus and metabolic profile at newborn screening. Included were 1,693,658 infants divided into a training or testing subset in a ratio of 3:1. Forty- two metabolites were analyzed using logistic regression (odds ratios (ORs), area under the receiver operating characteristic curve (AUC), 95% confidence intervals (CIs)). Several metabolite patterns remained consistent across gestational age groups for hyperbilirubinemia without kernicterus. Thyroid stimulating hormone (TSH) and C- 18:2 were decreased, whereas tyrosine and C- 3 were increased in infants across groupings. Increased C- 3 was also observed for kernicterus (OR: 3.17; 95% CI: 1.18–8.53). Thirty- one metabolites were associated with hyperbilirubinemia without kernicterus in the training set. Phenylalanine (OR: 1.91; 95% CI: 1.85–1.97), ornithine (OR: 0.76; 95% 0.74–0.77), and isoleucine + leucine (OR: 0.63; 95% CI: 0.61–0.65) were the most strongly associated. This study showed that newborn metabolic function is associated with hyper- bilirubinemia with and without kernicterus. Study Highlights WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE? ✔ A variety of neonatal and maternal characteristics are ✔ Forty-one infant metabolites collected at newborn known to be associated with increased risk of hyperbili- screening were shown to be associated with neonatal hy- rubinemia. -
Hyperbilirubinemia and Kernicterus Jesus Peinado PGY2 Merle Ipson MD March 2009 Hyperbilirubinemia
Hyperbilirubinemia and Kernicterus Jesus Peinado PGY2 Merle Ipson MD March 2009 Hyperbilirubinemia Most common clinical condition requiring evaluation and treatment in the NB Most common cause of readmission in the 1 st week Generally a benign transitional phenomenon May pose a direct threat of brain damage May evolve into kernicterus Kernicterus 1. Choreoathetoid cerebral palsy 2. High-frequency central neural hearing loss 3. Palsy of vertical gaze 4. Dental enamel hypoplasia (result of bilirubin-induced cell toxicity) Kernicterus Originally described in NB with Rh hemolytic disease Recently reported in healthy term and late preterm Reported in breast-fed infants w/out hemolysis Most prevalent risk factor is late preterm Late Preterm Infant Relatively immature in their capacity to handle unconjugated bilirubin Hyperbilirubinemia is more prevalent, pronounced and protracted Eightfold increased risk of developing TSB > 20 mg/dl (5.2%) compared to term (0.7%) Pathobiology Increased bilirubin load in the hepatocyte Decreased erythrocyte survival Increased erythrocyte volume Increased enterohepatic circulation Decreased hepatic uptake from plasma Defective bilirubin conjugation Bilirubin Metabolism Bilirubin Metabolism Bilirubin Metabolism How bilirubin Damages the Brain Determinants of neuronal injury by bilirubin 1. Concentration of unconjugated bilirubin 2. Free bilirubin 3. Concentration of serum albumin 4. Ability to bind UCB 5. Concentration of hydrogen ion 6. Neuronal susceptibility Intracellular Calcium Homeostasis -
Histological Findings in the Kernicterus-Associated Vulnerable
Palmela et al. Int J Pathol Clin Res 2015, 1:1 ISSN: 2469-5807 International Journal of Pathology and Clinical Research Research Article: Open Access Histological Findings in the Kernicterus-Associated Vulnerable Brain Regions are Linked to Neurodegeneration, Alterations in Astrocyte and Pericyte Distribution, and Vascular Modifications Inês Palmela1, Pedro Pereira2,3, Masaharu Hayashi4, Dora Brites1,5 and Maria A. Brito1,5* 1Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Portugal 2Laboratory of Neuropathology, Centro Hospitalar Lisboa Norte, Portugal 3Neuromuscular Unit, Institute of Molecular Medicine, Faculdade de Medicina, Universidade de Lisboa, Portugal 4Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Japan 5Department of Biochemistry and Human Biology, Faculdade de Farmácia, Universidade de Lisboa, Portugal *Corresponding author: Maria A. Brito, Medicines Research Institute (iMed. ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal, Tel: 351217946449, Fax: 351217946491, E-mail: [email protected] Abstract Keywords Kernicterus is a severe manifestation of neonatal unconjugated Astrogliosis, Basement membrane, Blood-brain barrier, Caveolae, hyperbilirubinemia. We investigated the neuro-glia-vascular Hyperpermeability, Kernicterus, Pericyte vascular coverage, alterations in autopsy material from three infants with kernicterus. Transcytosis, Unconjugated bilirubin, Vascularization Histological and immunohistochemical studies were performed in the cerebellum, hippocampus and basal ganglia, the most vulnerable brain regions to bilirubin-induced neurotoxicity. The data obtained Introduction were compared with the relatively spared temporal cortex, as well as with three aged-matched controls with no hyperbilirubinaemia. Neonatal jaundice is extremely common in the first week of Our data showed a reduction of the external germinal layer life, affecting 60 to 85% of neonates [1]. -
Polycythemia in the Newborn
AIIMS- NICU protocols 2007 Polycythemia in the Newborn Jeeva Sankar, Ramesh Agarwal,Deepak Chawla, Vinod K Paul ,Ashok Deorari Division of Neonatology, Department of Pediatrics WHO Collaborating Centre for Training & Research in Newborn Care All India Institute of Medical Sciences Ansari Nagar, New Delhi –110029 Address for correspondence: Dr Ashok Deorari Professor Department of Pediatrics All India Institute of Medical Sciences Ansari Nagar, New Delhi 110029 Email: [email protected] Downloaded from www.newbornwhocc.org 1 AIIMS- NICU protocols 2007 Abstract Polycythemia is defined as a venous hematocrit above 65%. The hematocrit in a newborn peaks at 2 hours of age and decreases gradually after that. The etiology of polycythemia is related either to intra-uterine hypoxia or secondary to fetal transfusion. The relationship between hematocrit and viscosity is almost linear till 65% and exponential thereafter. Increased viscosity of blood is associated with symptoms of hypo-perfusion. Clinical features related to hyperviscosity may affect all organ systems and this entity should be screened for in high-risk infants. Polycythemia maybe symptomatic or asymptomatic and guidelines for management of both types based on the current evidence are provided in the protocol. Downloaded from www.newbornwhocc.org 2 AIIMS- NICU protocols 2007 Polycythemia or an increased hematocrit is associated with hyperviscosity of blood. As the viscosity increases, there is an impairment of tissue oxygenation and perfusion and a tendency to form microthrombi. Significant damage may occur if these events occur in the cerebral cortex, kidneys and adrenal glands. Hence this condition requires urgent diagnosis and prompt management. Polycythemia and Hyperviscosity The viscosity of blood is directly proportional to the hematocrit and plasma viscosity and inversely proportional to the deformability of red blood cells. -
Study of Clinical Features and in Newborn with Polycythemi Antenatal
Research Article Study of clinical features and associated factors in newborn with polycythemia with high risk antenatal and natal factors R C Mahajan 1* , Lalit Une 2, Sharad Bansal 3 1Assistant Professor, 2Professor, 3Associate Professor, Department of Paedicatrics, JIIU ’s IIMSR Medical College, Warudi, Jalna, Maharashtra, INDIA. Email: [email protected] Abstract Introduction: Various risk factors such as birth asphyxia, toxemias of pregnancy (preeclampsia /eclampsia), twin pregnancies, hypertension, postmaturity, suspected intrauterine growth re tardation , maternal diabetes etc have been reported by various authors associated with polyc ythemia. Symptomatic children show wide range of symptoms such as lethargy, plethora or cyanosis, poor suck, drowsiness, jitteriness, seizures, myoclonic jerks, vomiting, tachypnea, tachycardia, hepatomegaly and jaundice. Aims and Objectives: To study the various clinical features and associated factors in newborn with polycythemia with high risk antenatal and natal factors. Materials and Methods: In the present study newborn with various high risk antenatal factors were enrolled. A detailed antenatal (medi cal and obstetric), intrapartum history of mother was recorded on a prestructured proforma. Complete clinical examination was done in newborns. Cord blood hematocrit determined was done by Wintrobe's hematocrit method from each of the newborns. Results: Ou t of total 200 newborns, 21 newborn were polycythemic. Most common high risk factor observed in the present study was birth asphyxia. And out of these 93 cases polycythemia was diagnosed in 9 newborns. Majority (13) of the polycythemic newborn were having hematoocrit between the range of 65% to 69%. Incidence of polytheminia in twin pregnancies was found to be 22.72%. It was observed that majority of the polycythemic newborn were having birth weight less than 2500gms.